Canine brain tumor trials: Meningioma

Liz Pluhar and team conducting brain surgery on a dog


Status: On hold
Principal Investigator: 
G. Elizabeth Pluhar
Michael Olin

G. Elizabeth Pluhar, DVM, PhD
[email protected]

Purpose of study

The goal of the Canine Brain Tumor Clinical Trial Program is to offer cutting edge therapy to dogs intended to preserve quality of life and improve long-term survival rates. Additionally, we will use the information gained from treating dogs to design similar treatments for people with brain tumors. The majority of the costs associated with these experimental brain tumor therapies are paid for by grants from foundation and government agencies including the Children’s Cancer Research Fund, the Randy Shaver Cancer Research and Community Fund, the National Institutes of Health, the American Cancer Society, the American Brain Tumor Association and the American Kennel Club Canine Health Foundation.

Eligibility criteria

We are no longer recruiting dogs for a clinical trial, but we are offering to treat dogs diagnosed with meningioma with surgery and vaccine-based immunotherapy. 


The vaccines had a 93% efficacy rate in the clinical trials we performed, and are an alternative to radiation therapy with or without surgery.